Inotiv Inc reports results for the quarter ended in January - Earnings Summary

Inotiv

15/05/2024 23:16

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss of
$1.86​​ per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of -39
cents.  The mean expectation of three analysts for the quarter
was for a loss of 54 cents per share. Wall Street expected
results to range from -74 cents to -34 cents per share.
    * Revenue fell 21.4% to $119.04 million from a year ago;
analysts
expected $129.78 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of
$1.86​.
    * The company reported a quarterly loss of $48.08 million.
    * Inotiv Inc shares had fallen by 80.6% this quarter and
lost 42.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is
$10.00 
This summary was machine generated from LSEG data May 15 at
10:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.54          -1.86          Missed
 Dec. 31 2023      -0.85          -0.60          Beat
 Sep. 30 2023      -0.33          -0.38          Missed
 Jun. 30 2023      -0.10          0.07           Beat